In May 2019, a demo at Nanjing College Clinic started comparing dapagliflozin to liraglutide, and also to the anti-diabetic medication acarbose, for their respective outcomes on cognitive and olfactory function in 87 overweight people whose Form two diabetic issues is poorly managed with metformin by itself. This cure could contain https://vonl666whr8.wikitelevisions.com/user